King Saud University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Riyadh Saudi Arabia (1957)

Organization Overview

First Clinical Trial
2003
NCT01167946
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Abrar Alzaher | AlJohara M AlQuaiz, M.D. | Assistant professor at King Saud university | Associate Professor & Consultant of Pediatric,Medical College, King Saud University | College of Medicine, King Saud University | College Of Medicine, King Saud University | Dallah hospital | Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University | Dr. Abdullah Alquwaihes | Dr. Khalid ALdybayan | Dr. Tariq Alhawassi | INSTITUTIONAL REVIEW BOARD King Saud University | King Saud Medical City | King Saud University | King Saud University Medical City, Riyadh,KSA. | King Saud University- Medical college | Ms. Haneen Molla | Rehabilitation Research Chair, CAMS, King Saud University, Riyadh, Saudi Arabia

Active Ingredients

Drugs in Phase 4 Trials (25)

atropine (1 trial)

brown seaweed (1 trial)

cimetidine (tagamet) (1 trial)

colistin (1 trial)

diltiazem (cardizem) (1 trial)

esomeprazole (nexium) (1 trial)

famotidine (pepcid) (1 trial)

fentanyl (Innovar) (2 trials)

insulin human (humulin) (2 trials)

lansoprazole (prevacid) (1 trial)

levobupivacaine (chirocaine) (3 trials)

metformin (glucophage) (1 trial)

methylprednisolone (medrol) (1 trial)

nizatidine (axid) (1 trial)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (1 trial)

polyethylene glycol (1 trial)

protecadin (1 trial)

rabeprazole (pariet) (1 trial)

remifentanil (ultiva) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sevoflurane (ultane) (1 trial)

sodium chloride (2 trials)

sorafenib (nexavar) (1 trial)

succinylcholine (anectine) (1 trial)

Drugs in Phase 3 Trials (19)

13c5-calcium-l-leucovorin (1 trial)

acetaminophen (tylenol) (1 trial)

acetylcysteine (mucomyst) (1 trial)

aminolevulinic acid (levulan) (1 trial)

bevacizumab (avastin) (1 trial)

budesonide (rhinocort) (1 trial)

capecitabine (xeloda) (1 trial)

curcumin (1 trial)

dexmedetomidine (precedex) (1 trial)

fluorouracil (efudex) (1 trial)

glucose monohydrate (1 trial)

indocyanine green (ic-green) (1 trial)

levothyroxine (Synthroid) (1 trial)

lidocaine (xylocaine) (2 trials)

nystatin (mycostatin) (1 trial)

oxaliplatin (eloxatin) (1 trial)

rose bengal disodium (1 trial)

urea (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 2 Trials (8)

bone marrow derived mesenchymal stem cells (1 trial)

caffeine (1 trial)

COVID-19 convalescent plasma (1 trial)

fiber (1 trial)

filgrastim (neupogen) (1 trial)

gabapentin (neurontin) (1 trial)

lactose (1 trial)

prednisolone (hydeltra) (1 trial)

Drugs in Phase 1 Trials (1)

salvadora persica root (1 trial)

Drugs in Other Trials (9)

etomidate (amidate) (1 trial)

glycerin (1 trial)

ketamine (ketalar) (1 trial)

platelet rich fibrin (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

probiotic (1 trial)

propofol (diprivan) (1 trial)

tinzaparin (Innohep) (1 trial)

yinhsing (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 4)

Alopecia Areata (Phase 4)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Carcinoma, Transitional Cell (Phase 3)

Cerebral Hemorrhage (Phase 3)

Chronic Periodontitis (Phase 1)

Colorectal Neoplasms (Phase 4)

Communicable Diseases (Phase 4)

Dyslipidemias (Phase 3)

Edema (Phase 3)

Emergencies (Phase 3)

End Stage Liver Disease (Phase 2)

Epilepsy (Phase 3)

Fissure in Ano (Phase 4)

Hemorrhage (Phase 3)

Hypothyroidism (Phase 3)

Infections (Phase 4)

Liver Diseases (Phase 2)

Macular Edema (Phase 3)

Multiple Sclerosis (Phase 2)

Narcolepsy (Phase 2)

Pain, Postoperative (Phase 1)

Peri-Implantitis (Phase 4)

Periodontitis (Phase 1)

Postoperative Complications (Phase 2)

Rectal Neoplasms (Phase 3)

Respiratory Aspiration of Gastric Contents (Phase 4)

Sclerosis (Phase 2)

Status Asthmaticus (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Vitamin D Deficiency (Phase 3)

Vitiligo (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 42
  • # of Trial APIs: 62